Hasil Pencarian - Rinaldo Zurbriggen

  • Menampilkan 1 - 6 hasil dari 6
Perbaiki Hasil
  1. 1
    Applications of Protein Epitope Mimetics in Vaccine Design. A New Supersecondary Structure in the Circumsporozoite Protein of Plasmodium falciparum?

    Applications of Protein Epitope Mimetics in Vaccine Design. A New Supersecondary Structure in the Circumsporozoite Protein of Plasmodium falciparum? oleh Bernhard Pfeiffer, Rafael Moreno, Kerstin Moehle, Rinaldo Zurbriggen, Reinhard Glück, Gerd Pluschke, John A. Robinson

    Diterbitkan 2001-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    A randomized placebo-controlled phase Ia malaria vaccine trial of two virosome-formulated synthetic peptides in healthy adult volunteers.

    A randomized placebo-controlled phase Ia malaria vaccine trial of two virosome-formulated synthetic peptides in healthy adult volunteers. oleh Blaise Genton, Gerd Pluschke, Lukas Degen, Andreas R Kammer, Nicole Westerfeld, Shinji L Okitsu, Sandro Schroller, Penelope Vounatsou, Markus M Mueller, Marcel Tanner, Rinaldo Zurbriggen

    Diterbitkan 2007-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    A virosomal malaria peptide vaccine elicits a long-lasting sporozoite-inhibitory antibody response in a phase 1a clinical trial.

    A virosomal malaria peptide vaccine elicits a long-lasting sporozoite-inhibitory antibody response in a phase 1a clinical trial. oleh Shinji L Okitsu, Olivier Silvie, Nicole Westerfeld, Marija Curcic, Andreas R Kammer, Markus S Mueller, Robert W Sauerwein, John A Robinson, Blaise Genton, Dominique Mazier, Rinaldo Zurbriggen, Gerd Pluschke

    Diterbitkan 2007-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Virosome-formulated Plasmodium falciparum AMA-1 & CSP derived peptides as malaria vaccine: randomized phase 1b trial in semi-immune adults & children.

    Virosome-formulated Plasmodium falciparum AMA-1 & CSP derived peptides as malaria vaccine: randomized phase 1b trial in semi-immune adults & children. oleh Patrick Georges Cech, Thomas Aebi, Mwanajaa Shomari Abdallah, Maxmillian Mpina, Ester Barnabas Machunda, Nicole Westerfeld, Sabine Alexandra Stoffel, Rinaldo Zurbriggen, Gerd Pluschke, Marcel Tanner, Claudia Daubenberger, Blaise Genton, Salim Abdulla

    Diterbitkan 2011-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Correction: Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial.

    Correction: Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial. oleh Fiona M. Thompson, David W. Porter, Shinji L. Okitsu, Nicole Westerfeld, Denise Vogel, Stephen Todryk, Ian Poulton, Simon Correa, Claire Hutchings, Tamara Berthoud, Susanna Dunachie, Laura Andrews, Jack L. Williams, Robert Sinden, Sarah C. Gilbert, Gerd Pluschke, Rinaldo Zurbriggen, Adrian V. S. Hill

    Diterbitkan 2011-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial.

    Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial. oleh Fiona M Thompson, David W Porter, Shinji L Okitsu, Nicole Westerfeld, Denise Vogel, Stephen Todryk, Ian Poulton, Simon Correa, Claire Hutchings, Tamara Berthoud, Susanna Dunachie, Laura Andrews, Jack L Williams, Robert Sinden, Sarah C Gilbert, Gerd Pluschke, Rinaldo Zurbriggen, Adrian V S Hill

    Diterbitkan 2008-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: